How mRNA Covid-19 vaccines could mean HIV cures and anti-cancer jabs


Daniel Bardsley
  • English
  • Arabic

The speed with which vaccines to protect against Covid-19 were created raises hopes that effective vaccines for other deadly viruses, which have long perplexed drug makers, may be within reach.

Clinical trials of Covid-19 vaccines began just months after the virus emerged in late 2019, and ultimately yielded positive results.

But a vaccine for HIV, the virus that causes Aids and kills almost 700,000 people every year, has eluded developers for more than three decades.

The global race to produce coronavirus vaccines, in particular the development of messenger RNA or mRNA technology, gives hope to researchers who struggled for years to produce treatments that could save millions of lives.

Vaccines take several forms, with some made from bacterial or viral particles treated to prevent virulence, while others consist of inactivated or weaker virus particles.

Yet more are made from components of the pathogen or, like the Oxford-AstraZeneca Covid-19 vaccine, consist of viral vectors that deliver genetic material into the cells of recipients.

Two of the earliest approved and most effective vaccines against coronavirus, from Pfizer-BioNTech and Moderna, are based on mRNA technology.

Unlike other kinds of vaccines, which give the body a weakened or inactive virus to cause the production of antibodies, mRNA vaccines make cells produce a protein that starts an immune response.

The new mRNA technology is being readied to fight HIV and other viruses, including those that cause influenza, which also claims hundreds of thousands of lives each year.

“The technology is now proven and shown to be highly effective,” said Prof Eskild Petersen, of the University of Aarhus in Denmark, and chairman of the emerging infections taskforce at the European Society of Clinical Microbiology and Infectious Diseases.

"So of course, you will try this technology will other infections."

Now that the basic technology has matured, new mRNA vaccines can be produced in as little as six weeks, and they are easier to make than some other vaccines, for which production may require growing bacterial or viral particles, where yields may fluctuate.

"The RNA vaccines are essentially chemical vaccines so the quality control aspects are much, much easier to control and it's much easier to make sure you have a routine product at the end," said Ian Jones, a professor of virology at the University of Reading in England.

Moderna, the US pharmaceutical company, has two dozen mRNA vaccines in development, with about half in clinical trials.

HIV, influenza and the Zika virus, among other pathogens, are the focus, and the company is also looking at therapeutic vaccines against cancer.

German company BioNTech has mRNA cancer therapeutics in clinical trials, along with vaccines against tuberculosis, HIV and an influenza vaccine developed with Pfizer.

Scientists did not expect it would take so long to develop a working vaccine against HIV, said Dr Andrew Freedman, an infectious diseases expert at Cardiff University in Wales.

“Undoubtedly one of the major problems is the extent to which HIV mutates, and there are lots and lots of different strains," Dr Freedman said.

"Even within one infected individual, there are lots of different viral species present."

While mRNA is another type of vaccine, Dr Freedman says that it is not able by itself to solve the issue of the virus’s variability.

Such a vaccine against HIV could be a step forward but "it's very premature to say this is going to be the answer".

There are also HIV vaccines under development that do not use mRNA technology.

The Jenner Institute at the University of Oxford, which developed the Oxford-AstraZeneca Covid-19 shot, is starting trials of an HIV vaccine that uses as the vector an adenovirus that normally infects chimpanzees.

This has genetic material coding for HIV proteins added.

In another illustration that cutting-edge vaccine development extends well beyond mRNA, the Jenner Institute is also behind a malaria vaccine consisting of virus-like particles, which was recently found to be 77 per cent effective in clinical trials.

The result was a significant step forward in the fight against a disease that kills about 400,000 people a year, mostly in sub-Saharan Africa.

Although there are efforts to develop mRNA vaccines against malaria, there are limits as to how widely the technology can be used.

Messenger RNA vaccines are not suitable replacements for complex vaccines used against bacterial infections, which can consist of as many as 15 components.

There will be a lot of diseases where it looks like it's going to change the nature of vaccination

Viruses may consist of just a handful of antigens – molecules that cause an immune response – while bacteria can contain thousands. It is harder to stimulate production inside human cells of many antigens using mRNA.

Bacterial vaccines may also require carbohydrate and lipid components, not just the proteins that mRNA vaccines help to create.

Although the technology cannot overcome all hurdles, David Taylor, professor emeritus of pharmaceutical and public health policy at University College London, said mRNA was likely to become "the favoured vaccine technology of the future".

“There will be a lot of diseases where it looks like it’s going to change the nature of vaccination,” Prof Taylor said.

“You’re delivering just a little fat capsule with just the RNA needed to make the protein you want to make.”

Likewise, Prof Jones regards mRNA vaccine technology as “a step change”, not least because it is now in commercial use.

“I think it has a very good future,” he said. “But not, perhaps, a future that is dramatically different from what has gone before, principally because it cannot address all vaccine issues or all vaccine types.”

There is also the question of how widely available mRNA vaccines will become. They can be costly, which may limit distribution in parts of the world with heavy infectious disease burdens.

“These are all patented technologies," Prof Jones said. "They’re not easily going to roll out to a mass market without the costs in the research being recovered in some way.

“There will be practical difficulties in rolling them out generally and quickly. But I do think as time goes on, their relative position in the vaccine market will inevitably grow.”

Key facilities
  • Olympic-size swimming pool with a split bulkhead for multi-use configurations, including water polo and 50m/25m training lanes
  • Premier League-standard football pitch
  • 400m Olympic running track
  • NBA-spec basketball court with auditorium
  • 600-seat auditorium
  • Spaces for historical and cultural exploration
  • An elevated football field that doubles as a helipad
  • Specialist robotics and science laboratories
  • AR and VR-enabled learning centres
  • Disruption Lab and Research Centre for developing entrepreneurial skills
Sole survivors
  • Cecelia Crocker was on board Northwest Airlines Flight 255 in 1987 when it crashed in Detroit, killing 154 people, including her parents and brother. The plane had hit a light pole on take off
  • George Lamson Jr, from Minnesota, was on a Galaxy Airlines flight that crashed in Reno in 1985, killing 68 people. His entire seat was launched out of the plane
  • Bahia Bakari, then 12, survived when a Yemenia Airways flight crashed near the Comoros in 2009, killing 152. She was found clinging to wreckage after floating in the ocean for 13 hours.
  • Jim Polehinke was the co-pilot and sole survivor of a 2006 Comair flight that crashed in Lexington, Kentucky, killing 49.
MOUNTAINHEAD REVIEW

Starring: Ramy Youssef, Steve Carell, Jason Schwartzman

Director: Jesse Armstrong

Rating: 3.5/5

The Bio

Favourite place in UAE: Al Rams pearling village

What one book should everyone read: Any book written before electricity was invented. When a writer willingly worked under candlelight, you know he/she had a real passion for their craft

Your favourite type of pearl: All of them. No pearl looks the same and each carries its own unique characteristics, like humans

Best time to swim in the sea: When there is enough light to see beneath the surface

MATCH INFO

Serie A

Juventus v Fiorentina, Saturday, 8pm (UAE)

Match is on BeIN Sports

Women’s World T20, Asia Qualifier

UAE results
Beat China by 16 runs
Lost to Thailand by 10 wickets
Beat Nepal by five runs
Beat Hong Kong by eight wickets
Beat Malaysia by 34 runs

Standings (P, W, l, NR, points)

1. Thailand 5 4 0 1 9
2. UAE 5 4 1 0 8
3. Nepal 5 2 1 2 6
4. Hong Kong 5 2 2 1 5
5. Malaysia 5 1 4 0 2
6. China 5 0 5 0 0

Final
Thailand v UAE, Monday, 7am

Company%20Profile
%3Cp%3E%3Cstrong%3EName%3A%3C%2Fstrong%3E%20Ovasave%3Cbr%3E%3Cstrong%3EStarted%3A%3C%2Fstrong%3E%20November%202022%3Cbr%3E%3Cstrong%3EFounders%3A%3C%2Fstrong%3E%20Majd%20Abu%20Zant%20and%20Torkia%20Mahloul%3Cbr%3E%3Cstrong%3EBased%3A%3C%2Fstrong%3E%20Abu%20Dhabi%3Cbr%3E%3Cstrong%3ESector%3A%3C%2Fstrong%3E%20Healthtech%3Cbr%3E%3Cstrong%3ENumber%20of%20staff%3A%3C%2Fstrong%3E%20Three%20employees%3Cbr%3E%3Cstrong%3EInvestment%20stage%3A%3C%2Fstrong%3E%20Pre-seed%3Cbr%3E%3Cstrong%3EInvestment%3A%3C%2Fstrong%3E%20%24400%2C000%3C%2Fp%3E%0A
Washmen Profile

Date Started: May 2015

Founders: Rami Shaar and Jad Halaoui

Based: Dubai, UAE

Sector: Laundry

Employees: 170

Funding: about $8m

Funders: Addventure, B&Y Partners, Clara Ventures, Cedar Mundi Partners, Henkel Ventures

Slow loris biog

From: Lonely Loris is a Sunda slow loris, one of nine species of the animal native to Indonesia, Malaysia, Thailand and Singapore

Status: Critically endangered, and listed as vulnerable on the International Union for Conservation of Nature red list due to growing demand in the global exotic pet trade. It is one of the most popular primate species found at Indonesian pet markets

Likes: Sleeping, which they do for up to 18 hours a day. When they are awake, they like to eat fruit, insects, small birds and reptiles and some types of vegetation

Dislikes: Sunlight. Being a nocturnal animal, the slow loris wakes around sunset and is active throughout the night

Superpowers: His dangerous elbows. The slow loris’s doe eyes may make it look cute, but it is also deadly. The only known venomous primate, it hisses and clasps its paws and can produce a venom from its elbow that can cause anaphylactic shock and even death in humans

Our legal consultant

Name: Hassan Mohsen Elhais

Position: legal consultant with Al Rowaad Advocates and Legal Consultants.

Defence review at a glance

• Increase defence spending to 2.5% of GDP by 2027 but given “turbulent times it may be necessary to go faster”

• Prioritise a shift towards working with AI and autonomous systems

• Invest in the resilience of military space systems.

• Number of active reserves should be increased by 20%

• More F-35 fighter jets required in the next decade

• New “hybrid Navy” with AUKUS submarines and autonomous vessels

UK-EU trade at a glance

EU fishing vessels guaranteed access to UK waters for 12 years

Co-operation on security initiatives and procurement of defence products

Youth experience scheme to work, study or volunteer in UK and EU countries

Smoother border management with use of e-gates

Cutting red tape on import and export of food

 


 

Labour dispute

The insured employee may still file an ILOE claim even if a labour dispute is ongoing post termination, but the insurer may suspend or reject payment, until the courts resolve the dispute, especially if the reason for termination is contested. The outcome of the labour court proceedings can directly affect eligibility.


- Abdullah Ishnaneh, Partner, BSA Law 

Our family matters legal consultant

Name: Hassan Mohsen Elhais

Position: legal consultant with Al Rowaad Advocates and Legal Consultants.

How to apply for a drone permit
  • Individuals must register on UAE Drone app or website using their UAE Pass
  • Add all their personal details, including name, nationality, passport number, Emiratis ID, email and phone number
  • Upload the training certificate from a centre accredited by the GCAA
  • Submit their request
What are the regulations?
  • Fly it within visual line of sight
  • Never over populated areas
  • Ensure maximum flying height of 400 feet (122 metres) above ground level is not crossed
  • Users must avoid flying over restricted areas listed on the UAE Drone app
  • Only fly the drone during the day, and never at night
  • Should have a live feed of the drone flight
  • Drones must weigh 5 kg or less
UAE Falcons

Carly Lewis (captain), Emily Fensome, Kelly Loy, Isabel Affley, Jessica Cronin, Jemma Eley, Jenna Guy, Kate Lewis, Megan Polley, Charlie Preston, Becki Quigley and Sophie Siffre. Deb Jones and Lucia Sdao – coach and assistant coach.